Advertisement
Screener

Clovis Oncology, Inc. Operating Expenses

Clovis Oncology, Inc. Operating Expenses

Clovis Oncology, Inc. reported Operating Expenses of $88.68 million for the 3-month period ending 2021-12-31, per its 10-K filed 2022-02-24.

Discontinued › Expense Statement › Operating Expenses

us-gaap:OperatingExpenses · last filed 2022-02-24

  • Clovis Oncology, Inc. operating expenses for the quarter ending 2021-12-31 was $88.68M, a 18.10% decline year-over-year.
  • Clovis Oncology, Inc. operating expenses for the quarter ending 2021-09-30 was $95.38M, a 14.32% decline year-over-year.
  • Clovis Oncology, Inc. operating expenses for the quarter ending 2021-06-30 was $94.40M, a 22.96% decline year-over-year.
  • Clovis Oncology, Inc. operating expenses for the quarter ending 2021-03-31 was $96.06M, a 22.89% decline year-over-year.
  • Clovis Oncology, Inc. operating expenses for fiscal 2020 was $466.71M, a 10.21% decline from fiscal 2019.
  • Clovis Oncology, Inc. operating expenses for fiscal 2019 was $519.75M, a 21.10% increase from fiscal 2018.
  • Clovis Oncology, Inc. operating expenses for fiscal 2018 was $429.20M, a 46.41% increase from fiscal 2017.
  • Clovis Oncology, Inc. operating expenses for fiscal 2017 was $293.14M, a 21.37% decline from fiscal 2016.
Period endOperating Expenses 3 monthOperating Expenses 6 monthOperating Expenses 9 monthOperating Expenses 12 monthOperating Expenses 56 month
2021-12-31$88.68M
10-K · filed 2022-02-24
$184.06M
derived: sum of 2 quarters · filed 2022-02-24
$278.46M
derived: sum of 3 quarters · filed 2022-02-24
$374.52M
derived: sum of 4 quarters · filed 2022-02-24
2021-09-30$95.38M
10-K · filed 2022-02-24
$189.78M
derived: sum of 2 quarters · filed 2022-02-24
$285.85M
derived: sum of 3 quarters · filed 2022-02-24
$394.13M
derived: sum of 4 quarters · filed 2022-02-24
2021-06-30$94.40M
10-K · filed 2022-02-24
$190.47M
10-Q · filed 2021-08-04
$298.75M
derived: sum of 3 quarters · filed 2022-02-24
$410.06M
derived: sum of 4 quarters · filed 2022-02-24
2021-03-31$96.06M
10-K · filed 2022-02-24
$204.34M
derived: sum of 2 quarters · filed 2022-02-24
$315.66M
derived: sum of 3 quarters · filed 2022-02-24
$438.20M
derived: sum of 4 quarters · filed 2022-02-24
2020-12-31$108.28M
10-K · filed 2022-02-24
$219.60M
derived: sum of 2 quarters · filed 2022-02-24
$342.13M
derived: sum of 3 quarters · filed 2022-02-24
$466.71M
10-K · filed 2021-02-25
2020-09-30$111.32M
10-K · filed 2022-02-24
$233.85M
derived: sum of 2 quarters · filed 2022-02-24
$358.43M
10-Q · filed 2020-11-05
$489.40M
derived: sum of 4 quarters · filed 2022-02-24
2020-06-30$122.53M
10-K · filed 2022-02-24
$247.11M
10-Q · filed 2021-08-04
$378.08M
derived: sum of 3 quarters · filed 2022-02-24
$522.11M
derived: sum of 4 quarters · filed 2022-02-24
2020-03-31$124.58M
10-K · filed 2022-02-24
$255.54M
derived: sum of 2 quarters · filed 2022-02-24
$399.57M
derived: sum of 3 quarters · filed 2022-02-24
$526.01M
derived: sum of 4 quarters · filed 2022-02-24
2019-12-31$130.97M
10-K · filed 2021-02-25
$275.00M
derived: sum of 2 quarters · filed 2021-02-25
$401.44M
derived: sum of 3 quarters · filed 2021-02-25
$519.75M
10-K · filed 2021-02-25
2019-09-30$144.03M
10-K · filed 2021-02-25
$270.47M
derived: sum of 2 quarters · filed 2021-02-25
$388.79M
10-Q · filed 2020-11-05
$516.10M
derived: sum of 4 quarters · filed 2021-02-25
2019-06-30$126.44M
10-K · filed 2021-02-25
$244.76M
10-Q · filed 2020-08-07
$372.07M
derived: sum of 3 quarters · filed 2021-02-25
$483.99M
derived: sum of 4 quarters · filed 2021-02-25
2019-03-31$118.32M
10-K · filed 2021-02-25
$245.63M
derived: sum of 2 quarters · filed 2021-02-25
$357.55M
derived: sum of 3 quarters · filed 2021-02-25
$460.32M
derived: sum of 4 quarters · filed 2021-02-25
2018-12-31$127.32M
10-K · filed 2020-02-26
$239.24M
derived: sum of 2 quarters · filed 2020-02-26
$342.01M
derived: sum of 3 quarters · filed 2020-02-26
$429.20M
10-K · filed 2021-02-25
2018-09-30$111.92M
10-K · filed 2020-02-26
$214.69M
derived: sum of 2 quarters · filed 2020-02-26
$301.88M
10-Q · filed 2019-11-07
$382.13M
derived: sum of 4 quarters · filed 2020-02-26
2018-06-30$102.77M
10-K · filed 2020-02-26
$189.96M
10-Q · filed 2019-08-02
$270.21M
derived: sum of 3 quarters · filed 2020-02-26
$347.54M
derived: sum of 4 quarters · filed 2020-02-26
2018-03-31$87.19M
10-K · filed 2020-02-26
$167.44M
derived: sum of 2 quarters · filed 2020-02-26
$244.77M
derived: sum of 3 quarters · filed 2020-02-26
$317.13M
derived: sum of 4 quarters · filed 2020-02-26
2017-12-31$80.24M
10-K · filed 2019-02-28
$157.58M
derived: sum of 2 quarters · filed 2019-02-28
$229.94M
derived: sum of 3 quarters · filed 2019-02-28
$293.14M
10-K · filed 2020-02-26
2017-09-30$77.33M
10-K · filed 2019-02-28
$149.69M
derived: sum of 2 quarters · filed 2019-02-28
$212.90M
10-Q · filed 2018-11-01
$280.11M
derived: sum of 4 quarters · filed 2019-02-28
2017-06-30$72.36M
10-K · filed 2019-02-28
$135.56M
10-Q · filed 2018-08-02
$202.78M
derived: sum of 3 quarters · filed 2019-02-28
$266.78M
derived: sum of 4 quarters · filed 2019-02-28
2017-03-31$63.21M
10-K · filed 2019-02-28
$130.42M
derived: sum of 2 quarters · filed 2019-02-28
$194.42M
derived: sum of 3 quarters · filed 2019-02-28
$351.07M
derived: sum of 4 quarters · filed 2019-02-28
2016-12-31$67.21M
10-K · filed 2018-02-27
$131.21M
derived: sum of 2 quarters · filed 2018-02-27
$287.86M
derived: sum of 3 quarters · filed 2018-02-27
$372.81M
10-K · filed 2019-02-28
2016-09-30$64.00M
10-K · filed 2018-02-27
$220.65M
derived: sum of 2 quarters · filed 2018-02-27
$305.60M
10-Q · filed 2017-11-02
$452.50M
derived: sum of 4 quarters · filed 2018-02-27
2016-06-30$156.65M
10-K · filed 2018-02-27
$241.60M
10-Q · filed 2017-08-03
$388.50M
derived: sum of 3 quarters · filed 2018-02-27
$485.76M
derived: sum of 4 quarters · filed 2018-02-27
2016-03-31$84.95M
10-K · filed 2018-02-27
$231.86M
derived: sum of 2 quarters · filed 2018-02-27
$329.11M
derived: sum of 3 quarters · filed 2018-02-27
$397.45M
derived: sum of 4 quarters · filed 2018-02-27
2015-12-31$146.91M
10-K · filed 2017-02-23
$244.16M
derived: sum of 2 quarters · filed 2017-02-23
$312.50M
derived: sum of 3 quarters · filed 2017-02-23
$376.72M
10-K · filed 2018-02-27
2015-09-30$97.25M
10-K · filed 2017-02-23
$165.59M
derived: sum of 2 quarters · filed 2017-02-23
$229.81M
10-Q · filed 2016-11-04
$283.70M
derived: sum of 4 quarters · filed 2017-02-23
2015-06-30$68.34M
10-K · filed 2017-02-23
$132.56M
10-Q · filed 2016-08-09
$186.45M
derived: sum of 3 quarters · filed 2017-02-23
$227.57M
derived: sum of 4 quarters · filed 2017-02-23
2015-03-31$64.22M
10-K · filed 2017-02-23
$118.11M
derived: sum of 2 quarters · filed 2017-02-23
$159.24M
derived: sum of 3 quarters · filed 2017-02-23
$194.20M
derived: sum of 4 quarters · filed 2017-02-23
2014-12-31$53.89M
10-K · filed 2016-02-29
$95.01M
derived: sum of 2 quarters · filed 2016-02-29
$129.98M
derived: sum of 3 quarters · filed 2016-02-29
$172.08M
10-K · filed 2017-02-23
2014-09-30$41.12M
10-K · filed 2016-02-29
$76.09M
derived: sum of 2 quarters · filed 2016-02-29
$118.19M
10-Q · filed 2015-11-06
$146.69M
derived: sum of 4 quarters · filed 2016-02-29
2014-06-30$34.97M
10-K · filed 2016-02-29
$77.07M
10-Q · filed 2015-08-07
$105.57M
derived: sum of 3 quarters · filed 2016-02-29
$125.94M
derived: sum of 4 quarters · filed 2016-02-29
2014-03-31$42.11M
10-K · filed 2016-02-29
$70.60M
derived: sum of 2 quarters · filed 2016-02-29
$90.98M
derived: sum of 3 quarters · filed 2016-02-29
$110.28M
derived: sum of 4 quarters · filed 2016-02-29
2013-12-31$28.49M
10-K · filed 2015-02-27
$48.87M
derived: sum of 2 quarters · filed 2015-02-27
$68.18M
derived: sum of 3 quarters · filed 2015-02-27
$83.77M
10-K · filed 2016-02-29
$267.82M
10-K · filed 2014-02-28
2013-09-30$20.38M
10-K · filed 2015-02-27
$39.68M
derived: sum of 2 quarters · filed 2015-02-27
$55.27M
10-Q · filed 2014-11-07
2013-06-30$19.31M
10-K · filed 2015-02-27
$34.90M
10-Q · filed 2014-08-08
2013-03-31$15.59M
10-K · filed 2015-02-27
2012-12-31$73.78M
10-K · filed 2015-02-27
2011-12-31$54.59M
10-K · filed 2014-02-28